New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response.

PubWeight™: 0.93^‹?›

🔗 View Article (PMID 25176973)

Published in Eur Respir Rev on September 01, 2014

Authors

Jessica Menis¹, Baktiar Hasan¹, Benjamin Besse²

Author Affiliations

1: Medical Dept, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. Statistical Dept, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. Dept of Cancer Medicine/Thoracic Unit, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
2: Medical Dept, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. Statistical Dept, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. Dept of Cancer Medicine/Thoracic Unit, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. benjamin.besse@gustaveroussy.fr.

Articles citing this ↘

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer (2015) 1.10

Combined integrated protocol/basket trial design for a first-in-human trial. Orphanet J Rare Dis (2016) 0.92

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC. Front Oncol (2016) 0.79

The changing landscape of clinical trial and approval processes in China. Nat Rev Clin Oncol (2017) 0.78

Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov. Genet Med (2015) 0.75

PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms. Clin Pharmacol Ther (2016) 0.75

An efficient basket trial design. Stat Med (2017) 0.75